Tonix Pharmaceuticals Holding (TNXP) Receivables - Net (2023 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Receivables - Net of $8.8 million for Q1 2026, up 166.3% year-over-year from $3.3 million in Q1 2025, and up 40.65% quarter-over-quarter from $6.3 million in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Receivables - Net (2023 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Receivables - Net history runs 4 years deep, the most recent figure standing at $8.8 million for Q1 2026.
- In Q1 2026, Receivables - Net rose 166.3% year-over-year to $8.8 million; the TTM figure through Mar 2026 stood at $8.8 million (up 166.3% YoY), while the FY2025 annual figure was $6.3 million, up 70.27% from the prior year.
- Receivables - Net for Q1 2026 stood at $8.8 million, up from $6.3 million in the prior quarter.
- The five-year high for Receivables - Net was $8.8 million in Q1 2026, with the low at $1.6 million in Q3 2023.
- The 4-year median for Receivables - Net is $3.4 million (2024), against an average of $3.9 million.
- The sharpest annual moves came in 2025 and 2026: Receivables - Net slumped 30.52% in 2025, then surged 166.3% in 2026.
- Tonix Pharmaceuticals Holding's Receivables - Net stood at $4.6 million in 2023, then fell by 19.76% to $3.7 million in 2024, then surged by 70.27% to $6.3 million in 2025, then surged by 40.65% to $8.8 million in 2026.
- Business Quant data shows TNXP's Receivables - Net at $8.8 million in Q1 2026, $6.3 million in Q4 2025, and $3.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.81 Mn |
| Jun 30, 2026 | 11.81 Mn |
| Mar 31, 2026 | 8.82 Mn |
| Mar 31, 2026 | 8.82 Mn |
| Dec 31, 2025 | 6.27 Mn |
| Dec 31, 2025 | 6.27 Mn |
| Sep 30, 2025 | 3.48 Mn |
| Sep 30, 2025 | 3.48 Mn |
| Jun 30, 2025 | 2.32 Mn |
| Jun 30, 2025 | 2.32 Mn |
| Mar 31, 2025 | 3.31 Mn |
| Mar 31, 2025 | 3.31 Mn |
| Dec 31, 2024 | 3.68 Mn |
| Dec 31, 2024 | 3.68 Mn |
| Sep 30, 2024 | 1.63 Mn |
| Sep 30, 2024 | 1.63 Mn |
| Jun 30, 2024 | 3.34 Mn |
| Jun 30, 2024 | 3.34 Mn |
| Dec 31, 2023 | 4.59 Mn |
| Dec 31, 2023 | 4.59 Mn |